Tags » FDA Regulations

Webinar On FDA Inspection and Medical Device Design Control

Scheduled On : Tuesday, July 28, 2015 at 13:00 Hrs  

Description :

Medical device firms are subject to design control requirements.  According to the recent FDA enforcement trends (including 2013), inadequate design control is frequently cited in 483s and FDA warning letters. 356 more words

Medical Device

The inherent risk surrounding nutraceuticals

Nutraceuticals, a $30 billion industry in the United States, come in the form of capsules, bars, drinks, lotions, pills, and powders. The medical and therapeutic benefits they claim to offer vary from renewed sexual drive, to enhanced athletic performance, to fewer wrinkles. 395 more words

Property & Casualty

Global Compliance 

Working closely with every business, our professionals interpret and guarantee compliance with regulative needs and verify however the firm will befittingly pursue international market opportunities. we have a tendency to monitor regulative trends and changes altogether jurisdictions within which the firm will business, and that we share info and collaborate with regulators to manage money market risk. 89 more words

Complaince Training

Onsite Training

Looking to fulfil a coaching got to get the simplest for your business and employees? got to fulfil regulative or organisational coaching necessities? or simply need to induce those all necessary qualifications? 125 more words

Complaince Training

Webinar On Managing the FDA form "483": Inspection Observations

Description :

This webinar is a complete guide on how to manage the FDA’s 483 observations during and after an inspection. How you respond can make or break you. 151 more words

Life Science

Webinar On FDA’s 21 CFR Part 11 Add-on Inspections

Scheduled On : Tuesday, March 24, 2015 at 13:00 Hrs

Description :

This presentation will cover the scope, status and results of the surveillance inspections and what they may mean for the future of 21 CFR Part 11. 246 more words

Life Science